• Jun 2015Special Topics

    Patient Safety: Diagnosis and Treatment of Malignant Hyperthermia

    1.00 AMA PRA Category 1 Credit

    1.00 Patient Safety Credits
    Member: $50
    Non-Member: $100
    Sponsored by the American Society of Plastic Surgeons® (ASPS®)
      
    Author: Plastic Surgery Education Network
     
    Accreditation Statement
    The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
     
    Designation Statement
    The ASPS designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    Patient Safety Credit: 1.0
    Media: Interactive Learning
    Release Date: June 15, 2015
    Expiration Date: July 1, 2018
    Estimated time to complete this course: 1.0 hour
    Minimum Post-test Score to Claim Credit: 80%
     
    Intended Audience
    This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.
     
    Educational Overview
    Malignant hyperthermia is an inherited skeletal muscle disorder which presents as a hypermetabolic reaction to potent volatile anesthetic gases and some depolarizing muscle relaxants. This course will provide screening recommendations to assist medical professionals in identifying risk factors and clinical signs of malignant hyperthermia.  This course will also provide recommendations for perioperative measures, which will aid in increasing positive surgical outcomes for plastic surgery patients.
     
    Learning Objectives
    Upon completion of the online course, the participant should be able to:

    1.       Identify the clinical signs of malignant hyperthermia
    2.       Screen patients for malignant hyperthermia
    3.       Implement perioperative measures to improve the safety of patients at risk of malignant hyperthermia
    4.       Recognize and optimally treat acute malignant hyperthermia
     
    Disclosures:
    All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.
    Note: After purchasing online courses, you will get an email from onlineeducation@plasticsurgery.org with confirmation of purchase and instructions on how to access your online courses. You will be able to verify or change your email when you checkout.